These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34689350)

  • 1. Allele and genotype frequencies of CYP3A4, CYP3A5, CYP3A7, and GSTP1 gene polymorphisms among mainland Tibetan, Mongolian, Uyghur, and Han Chinese populations.
    Qi G; Han C; Zhou Y; Wang X
    Clin Exp Pharmacol Physiol; 2022 Feb; 49(2):219-227. PubMed ID: 34689350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP3A7, CYP3A4, and CYP3A5 genetic polymorphisms in recipients rather than donors influence tacrolimus concentrations in the early stages after liver transplantation.
    Dong Y; Xu Q; Li R; Tao Y; Zhang Q; Li J; Ma Z; Shen C; Zhong M; Wang Z; Qiu X
    Gene; 2022 Jan; 809():146007. PubMed ID: 34688813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic contribution to variable human CYP3A-mediated metabolism.
    Lamba JK; Lin YS; Schuetz EG; Thummel KE
    Adv Drug Deliv Rev; 2002 Nov; 54(10):1271-94. PubMed ID: 12406645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP3A5 and CYP3A7 genetic polymorphisms affect tacrolimus concentration in pediatric patients with nephrotic range proteinuria.
    Liu H; Xu Q; Huang W; Zhao Q; Jiang Z; Kuang X; Li Z; Sun H; Qiu X
    Eur J Clin Pharmacol; 2019 Nov; 75(11):1533-1540. PubMed ID: 31401678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional allele and genotype frequencies of CYP1A2, CYP2B6 and iNOS among mainland Chinese Tibetan, Mongolian, Uygur and Han populations.
    Qi GZ; Zhang ZY; Wang X; Yin SJ; Lou YQ; Zhang GL
    J Clin Pharm Ther; 2016 Feb; 41(1):84-91. PubMed ID: 26763760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allele and genotype frequencies of CYP3A4, CYP2C19, and CYP2D6 in Han, Uighur, Hui, and Mongolian Chinese populations.
    Zuo LJ; Guo T; Xia DY; Jia LH
    Genet Test Mol Biomarkers; 2012 Feb; 16(2):102-8. PubMed ID: 22224559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms of the drug-metabolizing enzyme cytochrome P450 3A5 in a Uyghur Chinese population.
    Chen Z; Li J; Chen P; Wang F; Zhang N; Yang M; Jin T; Chen C
    Xenobiotica; 2016 Sep; 46(9):850-6. PubMed ID: 26739429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms of drug-metabolizing phase I enzymes CYP3A4, CYP2C9, CYP2C19 and CYP2D6 in Han, Uighur, Hui and Mongolian Chinese populations.
    Zuo J; Xia D; Jia L; Guo T
    Pharmazie; 2012 Jul; 67(7):639-44. PubMed ID: 22888523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450 (CYP3A4*18) and glutathione-S-transferase (GSTP1) polymorphisms in a healthy Tunisian population.
    Zaied C; Abid S; Mtiraoui N; Zellema D; Achour A; Bacha H
    Genet Test Mol Biomarkers; 2012 Oct; 16(10):1184-7. PubMed ID: 22971138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms of the CYP3A4, CYP3A5, CYP3A7 and CYP1A2 among the Jordanian population.
    Salameh G; Al Hadidi K; El Khateeb M
    Environ Toxicol Pharmacol; 2012 Jul; 34(1):23-33. PubMed ID: 22426036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifying Role of GSTP1 Polymorphism on the Association between Tea Fluoride Exposure and the Brick-Tea Type Fluorosis.
    Wu J; Wang W; Liu Y; Sun J; Ye Y; Li B; Liu X; Liu H; Sun Z; Li M; Cui J; Sun D; Yang Y; Gao Y
    PLoS One; 2015; 10(6):e0128280. PubMed ID: 26046522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP3A5*3 and MDR-1 C3435T single nucleotide polymorphisms in six Chinese ethnic groups.
    Lai Y; Zhang J; Wang YX; Wang XD; Li JL; Wang YH; Zeng YJ; Huang M
    Pharmazie; 2011 Feb; 66(2):136-40. PubMed ID: 21434577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic analysis of drug metabolizing phase-I enzymes CYP3A4 in Tibetan populations.
    Liu L; Chang Y; Du S; Shi X; Yang H; Kang L; Jin T; Yuan D; He Y
    J Genet; 2017 Jun; 96(2):219-225. PubMed ID: 28674221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP3A Polymorphism and Chronic Mercury Intoxication.
    Chernyak YI; Merinova AP
    Bull Exp Biol Med; 2020 Feb; 168(4):492-495. PubMed ID: 32146629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP3A4 and CYP3A5 genotyping by Pyrosequencing.
    Garsa AA; McLeod HL; Marsh S
    BMC Med Genet; 2005 May; 6():19. PubMed ID: 15882469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of CYP3A and ABCB1 polymorphisms on cyclosporine concentrations in renal transplant recipients.
    Sun B; Guo Y; Gao J; Shi W; Fan G; Li X; Qiu J; Qin Y; Liu G
    Pharmacogenomics; 2017 Nov; 18(16):1503-1513. PubMed ID: 28952408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of CYP3A4*1B and CYP3A5*3 polymorphisms in population of Bosnia and Herzegovina.
    Semiz S; Dujić T; Ostanek B; Prnjavorac B; Bego T; Malenica M; Mlinar B; Marc J; Causević A
    Med Glas (Zenica); 2011 Feb; 8(1):84-9. PubMed ID: 21263403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP3A5*3 and CYP3A4*18 single nucleotide polymorphisms in a Chinese population.
    Hu YF; He J; Chen GL; Wang D; Liu ZQ; Zhang C; Duan LF; Zhou HH
    Clin Chim Acta; 2005 Mar; 353(1-2):187-92. PubMed ID: 15698606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deciphering DMET genetic data: comprehensive assessment of Northwestern Han, Tibetan, Uyghur populations and their comparison to eleven 1000 genome populations.
    Zhang J; Wang H; Niu G; Liu Y; Wang Y; Zhang L; Pei Y; Zhu H; Dai P; Chen C
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S1176-S1185. PubMed ID: 30688101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening CYP3A single nucleotide polymorphisms in a Han Chinese population with a genotyping chip.
    Liu CH; Peck K; Huang JD; Lin MS; Wang CH; Hsu WP; Wang HW; Lee HL; Lai ML
    Pharmacogenomics; 2005 Oct; 6(7):731-47. PubMed ID: 16207150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.